 |
 |
 |
 |
Pharmerit International Pharmerit International is a research organization based in Rotterdam in the Netherlands, Bethesda, MD in the USA, and York in the United Kingdom. Pharmerit helps define, build and communicate your product’s clinical, humanistic and economic value via a wide range of research activities.
For more background information, please visit our website
Pharmerit International keeps on growing! The US and NL offices have moved to larger accomodations due to recent company growth and to prepare for further expansion in the near future. The new locations are:
Pharmerit North America (USA)
Pharmerit Europe (NL)
New employees In the last quarter the following new employees have joined Pharmerit International:
For more information about our new employees, please visit the website.
Unsubscribe
If you do not wish to receive our newsletter again, you can unsubscribe by using the link in the e-mail version of the newsletter.
|
Pharmerit International Celebrates 10 Years
Since 2000, Pharmerit International has evolved from a small research consultancy firm to a thriving business with an international scope. We offer a comprehensive range of research activities, including health economics evaluations & modeling, outcomes research, comparative effectiveness, meta-analyses, market access, pricing & reimbursement research, health economic & reimbursement dossiers, and strategic positioning & health policy research
"What started out 10 years ago has steadily grown into a business far exceeding anyone's expectations" said Lex Tergau, co-founder and managing partner. "We are all very proud of this accomplishment and grateful to our clients and employees who helped us get there" ISPOR Meeting, Atlanta, May 15-19 2010 
The International Society for Pharmacoeconomics and Outcomes Research (ISPOR) meeting offers an ideal opportunity for sharing knowledge and new developments, and discussing them with others in the field of health economics and outcomes research. Are you interested in the research we are conducting? Please visit our booth (no. #1-2)
Pharmerit’s Staff Contributions to ISPOR 15th Annual International Meeting in Atlanta, Georgia, USA:
Short Course Saturday May 15th, 13:00 - 17:00 Modeling: Design and structure of a model
Research Presentations Session I, Monday May 17th, 13:45 – 14:45 Research on Pro Methods - Utility methods: Evaluating the measurement properties of an augmented EQ-5D with the inclusion of two single QoL indicators using the MEPS
Poster Presentations Session I, Monday May 17th, 18:30 - 19:30 Diabetes/Endocrine Disorders: Assessing the impact of painful diabetic peripheral neuropathy or post-herpetic neuralgia related health impairment on loss of productive time(PDB36) Session II, Tuesday May 19th, 18:00 - 19:00 Mental Health: Discrete event simulation model in major depressive disorder: life-time health outcomes of adjunctive atypical antipsychotics (PMH11) The comparative efficacy and safety of adjunctive antipsychotics in major depressive disorder patients that failed to respond to conventional antidepressants (PMH16) Neurological Disorders: The value of a predictive diagnostic blood test in multiple sclerosis (PND2) Session III, Wednesday May 20th, 11:45 - 12:45 Cardiovascular Disorders: Cost-effectiveness of atorvastatin in acute coronary syndrome patients in Spain (PCV85) Cost-effectiveness of atorvastatin in acute coronary syndrome patients in Sweden (PCV90) Infection: Clinical and economic outcomes of invasive aspergillosis in the chronic obstructive pulmonary disease non-traditional host: a hospital database analysis (PIN10) Systematic Disorders/Conditions: Comparing the TTO the VAS and the EQ-5D value-sets in patients treated with painful diabetic peripheral neuropathy or post-herpetic neuralgia (PSY37) Association between self-reported neuropathic pain severity and the EQ-5D in patients with diabetic peripheral neuropathy or post-herpetic neuralgia (PSY42) |
||
 |